|
||
By



From * LeukoSite, Inc., Cambridge, Massachusetts 02142; Chemokine receptors serve as coreceptors for HIV entry into CD4+ cells. Their expression is
thought to determine the tropism of viral strains for different cell types, and also to influence susceptibility to infection and rates of disease progression. Of the chemokine receptors, CCR5
is the most important for viral transmission, since CCR5 is the principal receptor for primary, macrophage-tropic viruses, and individuals homozygous for a defective CCR5 allele (
Aaron Diamond AIDS Research Center,
The Rockefeller University, New York 10016; § Division of Human Retrovirology, Dana-Faber
Cancer Institute, Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115;
and
Department of Cancer Biology, Harvard School of Public Health, Boston, Massachusetts 02115
32/
32) are highly resistant to infection with HIV-1. In this study, CCR5-specific mAbs were
generated using transfectants expressing high levels of CCR5. The specificity of these mAbs
was confirmed using a broad panel of chemokine receptor transfectants, and by their non-reactivity with T cells from
32/
32 individuals. CCR5 showed a distinct pattern of expression,
being abundant on long-term activated, IL-2-stimulated T cells, on a subset of effector/memory T cells in blood, and on tissue macrophages. A comparison of normal and CCR5
32 heterozygotes revealed markedly reduced expression of CCR5 on T cells from the heterozygotes. There was considerable individual to individual variability in the expression of CCR5 on
blood T cells, that related to factors other than CCR5 genotype. Low expression of CCR5
correlated with the reduced infectability of T cells with macrophage-tropic HIV-1, in vitro.
Anti-CCR5 mAbs inhibited the infection of PBMC by macrophage-tropic HIV-1 in vitro,
but did not inhibit infection by T cell-tropic virus. Anti-CCR5 mAbs were poor inhibitors of
chemokine binding, indicating that HIV-1 and ligands bind to separate, but overlapping regions of CCR5. These results illustrate many of the important biological features of CCR5,
and demonstrate the feasibility of blocking macrophage-tropic HIV-1 entry into cells with an
anti-CCR5 reagent.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|